Patterns of high-dose morphine use in a home-care hospice service: Should we be afraid of it?

Cancer

Volumn 101, Issue 6, 2004, Pages 1473-1477

  Bercovitch, Michaela ^a,b,c   Adunsky, Abraham ^a,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b Israel Cancer Association   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Home care; Hospice; Morphine; Pain; Survival

Indexed keywords

MORPHINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONSTIPATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL CARCINOMA; HOME CARE; HOSPICE; HUMAN; LIFE EXPECTANCY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYOCLONUS; NAUSEA; OUTPATIENT CARE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SEX DIFFERENCE; SIDE EFFECT; SURVIVAL TIME; TERMINAL CARE; URINE RETENTION; VOMITING; XEROSTOMIA;

AGED; FEASIBILITY STUDIES; FEMALE; HOME CARE SERVICES; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN, INTRACTABLE; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TERMINAL CARE;

EID: 4444378835     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20485     Document Type: Article

References (16)

1. Townsend J, Frank AO, Fermont D, et al. Terminal cancer care and patients' preferences for place of death. A prospective study. BMJ. 1990;301:415-417.
2. Gallo WT, Baker MJ, Bradley EH. Factors associated with home versus institutional death among cancer patients in Connecticut. J Am Geriatr Soc. 2001;49:771-777.
3. Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten year trends in the place of death of cancer patients in England. Palliat Med. 1998;12:353-363.
4. Zenz M, Willweber-Strumpf A. Opioiphobia and cancer pain in Europe. Lancet. 1993;341:1075-1076.
5. Ward SE, Goldberg N, Miller-McCaulley V, et al. Patient related barriers to management of cancer pain. Pain. 1993; 52:319-324.
6. Sawe J. High dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet. 1986;11:87-106.
7. Radbruch L, Grond S, Zech DJ, Bischoff A. High dose oral morphine in cancer pain management: a report of twelve cases. J Clin Anesth. 1996;8:144-150.
8. Bercovitch M, Waller A, Adunsky A. High dose morphine use in the hospice setting: data base survey of inpatients' characteristics and effects on life expectancy. Cancer. 1999;80: 1117-1123.
9. Bruera E, Scholler T, Wenk R, et al. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage. 1995;10:348-355.
10. Dixon WJ. BMDP statistical software. San Francisco: University of California Press, 1990.
11. Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium. Drugs. 2001;61:955-977.
12. World Health Organization. Cancer pain relief with a guide to opioid availability. Geneva: World Health Organization, 1996.
13. Mercadante S, Dardanoni G, Salvaggio L, Armata MG, Agnello A. Monitoring of opioid therapy in advanced cancer pain patients'. J Pain Symptom Manage. 1997;13:204-212.
14. Vigano A, Bruera E, Suarez-Almazor ME. Age, pain intensity and opioid dose in patients with advanced cancer. Cancer. 1998;83:1244-1250.
15. Christakis NA, Escarce JJ. Survival of Medicare patients after enrolment in hospice programs. N Engl J Med. 1996;335: 172-178.
16. Boyd KJ. The working patterns of hospice based home-care teams. Palliat Med. 1992;6:131-139.